Literature DB >> 29797039

[Imaging of abdominal tumors in childhood and adolescence : Part I: Background, hepatic, splenic and pancreatic tumors].

D M Renz1, H-J Mentzel2.   

Abstract

In comparison to adult patients, other specific entities of abdominal tumors occur in childhood and adolescence. These include malignant tumors originating from embryonic tissue, such as hepatoblastoma. Some of the abdominal tumors are already diagnosed prenatally or in neonates. Sonography functions as the primary radiological basic diagnostics of pediatric abdominal space-occupying lesions, if necessary supplemented by administration of ultrasound contrast medium or the implementation of novel techniques (e.g. innovative Doppler and elastography procedures). Magnetic resonance imaging (MRI) is used for a comprehensive and detailed depiction of the tumors including the question of resectability and vascular supply. Various weighting and different MRI sequences are used in order to be able to assess the signal behavior of the tumor and therefore the possible presence of calcification, necrosis or hemorrhage, the behavior of dynamic contrast enhancement, and the presence and extent of diffusion disorders. This information is decisive in order to be able to assess the entity and malignancy of the abdominal space-occupying lesion. Rare but relevant tumors with respect to the entity occur in childhood and adolescence in the abdominal organs liver, spleen and pancreas.

Entities:  

Keywords:  Abdominal neoplasms; Child; Diagnostic imaging; Magnetic resonance imaging; Sonography

Mesh:

Year:  2018        PMID: 29797039     DOI: 10.1007/s00117-018-0395-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

Review 1.  Focal splenic lesions: US findings.

Authors:  M Caremani; U Occhini; A Caremani; D Tacconi; L Lapini; A Accorsi; C Mazzarelli
Journal:  J Ultrasound       Date:  2013-05-04

Review 2.  Imaging of pediatric pancreatic neoplasms with radiologic-histopathologic correlation.

Authors:  Narendra S Shet; Bonnie L Cole; Ramesh S Iyer
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

3.  Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project.

Authors:  C A Stiller; J Pritchard; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2006-09       Impact factor: 9.162

4.  From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors.

Authors:  Ellen M Chung; Grant E Lattin; Regino Cube; Rachel B Lewis; Carlos Marichal-Hernández; Robert Shawhan; Richard M Conran
Journal:  Radiographics       Date:  2011 Mar-Apr       Impact factor: 5.333

5.  Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?

Authors:  Pablo Caro-Domínguez; Abha A Gupta; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2017-09-18

Review 6.  Malignant abdominal masses in children: quick guide to evaluation and diagnosis.

Authors:  Carla B Golden; James H Feusner
Journal:  Pediatr Clin North Am       Date:  2002-12       Impact factor: 3.278

Review 7.  Ultrasound body applications in children.

Authors:  Beverley Newman
Journal:  Pediatr Radiol       Date:  2011-08-17

Review 8.  Wilms tumor.

Authors:  Andrew M Davidoff
Journal:  Adv Pediatr       Date:  2012

Review 9.  From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation.

Authors:  Robert M Abbott; Angela D Levy; Nadine S Aguilera; Luis Gorospe; William M Thompson
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

Review 10.  Neuroblastoma and nephroblastoma: a radiological review.

Authors:  Maureen Dumba; Noorulhuda Jawad; Kieran McHugh
Journal:  Cancer Imaging       Date:  2015-04-08       Impact factor: 3.909

View more
  1 in total

Review 1.  [Imaging of tumor predisposition syndromes].

Authors:  K Glutig; A Pfeil; D M Renz
Journal:  Radiologe       Date:  2021-06-25       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.